公司资料
Citius Pharma 股价、新闻与催化剂
- 股票代码:
- CTXR
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.56 USD (-25.62%)
收盘价
最后更新: 2026年8月17日
16.6M USD
市值
股价为何变动
As of Aug 17, 2026, CTXR closed down 25.6% at $0.5620. No new same-company headline was identified in the current news window.
公司概览
业务概览
Citius Pharma is a specialty pharmaceutical company focused on anti-infective, oncology-supportive, and hospital-related products. Its story is centered on commercializing a small number of highly specific healthcare assets.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Citius sits in specialty biopharma.
商业模式特征
The business depends on product development, regulatory steps, and the ability to create commercial value from focused assets.
生物医药行业定位
Citius is a small-cap specialty-pharma name whose stock is driven by launch and regulatory milestones.
未来催化剂
- Citius’s catalysts are LYMPHIR and Mino-Lok-related updates, with the market watching whether the company can finally turn its infection-control story into something more durable. The next event that matters is the one that confirms the company still has a viable commercial path.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。